Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 997

1.

Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis.

Wu Y, Levis B, Riehm KE, Saadat N, Levis AW, Azar M, Rice DB, Boruff J, Cuijpers P, Gilbody S, Ioannidis JPA, Kloda LA, McMillan D, Patten SB, Shrier I, Ziegelstein RC, Akena DH, Arroll B, Ayalon L, Baradaran HR, Baron M, Bombardier CH, Butterworth P, Carter G, Chagas MH, Chan JCN, Cholera R, Conwell Y, de Man-van Ginkel JM, Fann JR, Fischer FH, Fung D, Gelaye B, Goodyear-Smith F, Greeno CG, Hall BJ, Harrison PA, Härter M, Hegerl U, Hides L, Hobfoll SE, Hudson M, Hyphantis T, Inagaki MD, Jetté N, Khamseh ME, Kiely KM, Kwan Y, Lamers F, Liu SI, Lotrakul M, Loureiro SR, Löwe B, McGuire A, Mohd-Sidik S, Munhoz TN, Muramatsu K, Osório FL, Patel V, Pence BW, Persoons P, Picardi A, Reuter K, Rooney AG, Santos IS, Shaaban J, Sidebottom A, Simning A, Stafford MD, Sung S, Tan PLL, Turner A, van Weert HC, White J, Whooley MA, Winkley K, Yamada M, Benedetti A, Thombs BD.

Psychol Med. 2019 Jul 12:1-13. doi: 10.1017/S0033291719001314. [Epub ahead of print]

PMID:
31298180
2.

A systematic review of the genetic mechanisms of dolutegravir resistance.

Rhee SY, Grant PM, Tzou PL, Barrow G, Harrigan PR, Ioannidis JPA, Shafer RW.

J Antimicrob Chemother. 2019 Jul 5. pii: dkz256. doi: 10.1093/jac/dkz256. [Epub ahead of print]

PMID:
31280314
3.

A limited number of medicines pragmatic trials had potential for waived informed consent following the 2016 CIOMS ethical guidelines.

Dal-Ré R, Avendaño-Solà C, de Boer A, James SK, Rosendaal FR, Stephens R, Ioannidis JPA.

J Clin Epidemiol. 2019 Jun 15;114:60-71. doi: 10.1016/j.jclinepi.2019.06.007. [Epub ahead of print]

PMID:
31212001
4.

A user's guide to inflated and manipulated impact factors.

Ioannidis JPA, Thombs BD.

Eur J Clin Invest. 2019 Jun 17:e13151. doi: 10.1111/eci.13151. [Epub ahead of print] No abstract available.

PMID:
31206647
5.

Solutions to Reduce Unnecessary Imaging-Reply.

Oren O, Kebebew E, Ioannidis JPA.

JAMA. 2019 Jun 11;321(22):2243. doi: 10.1001/jama.2019.4021. No abstract available.

PMID:
31184737
6.

Interventions to improve cardiopulmonary resuscitation: a review of meta-analyses and future agenda.

Chalkias A, Ioannidis JPA.

Crit Care. 2019 Jun 7;23(1):210. doi: 10.1186/s13054-019-2495-5. No abstract available.

7.

Risk and protective factors for anxiety and obsessive-compulsive disorders: an umbrella review of systematic reviews and meta-analyses.

Fullana MA, Tortella-Feliu M, Fernández de la Cruz L, Chamorro J, Pérez-Vigil A, Ioannidis JPA, Solanes A, Guardiola M, Almodóvar C, Miranda-Olivos R, Ramella-Cravaro V, Vilar A, Reichenberg A, Mataix-Cols D, Vieta E, Fusar-Poli P, Fatjó-Vilas M, Radua J.

Psychol Med. 2019 Jun 7:1-16. doi: 10.1017/S0033291719001247. [Epub ahead of print]

PMID:
31172897
8.

Family History-Wide Association Study ("FamWAS") for Identifying Clinical and Environmental Risk Factors for Common Chronic Diseases.

Rasooly D, Ioannidis JPA, Khoury MJ, Patel CJ.

Am J Epidemiol. 2019 Jun 7. pii: kwz125. doi: 10.1093/aje/kwz125. [Epub ahead of print]

PMID:
31172187
9.

Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies.

Ladanie A, Speich B, Briel M, Sclafani F, Bucher HC, Agarwal A, Ioannidis JPA, Pereira TV, Kasenda B, Hemkens LG.

J Clin Epidemiol. 2019 May 31;114:49-59. doi: 10.1016/j.jclinepi.2019.05.033. [Epub ahead of print]

PMID:
31158450
10.

Validation protocols for blood pressure measuring devices: the impact of the European Society of Hypertension International Protocol and the development of a Universal Standard.

O'Brien E, Stergiou G, Palatini P, Asmar R, Ioannidis JP, Kollias A, Lacy P, McManus RJ, Myers MG, Shennan A, Wang J, Parati G; European Society of Hypertension Working Group on Blood Pressure Monitoring.

Blood Press Monit. 2019 Aug;24(4):163-166. doi: 10.1097/MBP.0000000000000391.

PMID:
31116156
11.

Lost Evidence From Registered Large Long-Unpublished Randomized Controlled Trials: A Survey.

Tatsioni A, Karassa FB, Goodman SN, Zarin DA, Fanelli D, Ioannidis JPA.

Ann Intern Med. 2019 May 7. doi: 10.7326/M19-0440. [Epub ahead of print] No abstract available.

PMID:
31060046
12.

Lethal news: The dexterous infiltration of news media by the tobacco industry agenda.

Ioannidis JPA.

Eur J Clin Invest. 2019 Jul;49(7):e13125. doi: 10.1111/eci.13125. Epub 2019 May 18. No abstract available.

PMID:
31058313
13.

Consent insufficient for data release-Response.

Amann RI, Baichoo S, Blencowe BJ, Bork P, Borodovsky M, Brooksbank C, Chain PSG, Colwell RR, Daffonchio DG, Danchin A, de Lorenzo V, Dorrestein PC, Finn RD, Fraser CM, Gilbert JA, Hallam SJ, Hugenholtz P, Ioannidis JPA, Jansson JK, Kim JF, Klenk HP, Klotz MG, Knight R, Konstantinidis KT, Kyrpides NC, Mason CE, McHardy AC, Meyer F, Ouzounis CA, Patrinos AAN, Podar M, Pollard KS, Ravel J, Muñoz AR, Roberts RJ, Rosselló-Móra R, Sansone SA, Schloss PD, Schriml LM, Setubal JC, Sorek R, Stevens RL, Tiedje JM, Turjanski A, Tyson GW, Ussery DW, Weinstock GM, White O, Whitman WB, Xenarios I.

Science. 2019 May 3;364(6439):446. doi: 10.1126/science.aax7509. No abstract available.

PMID:
31048484
14.

Reproducible pharmacokinetics.

Ioannidis JPA.

J Pharmacokinet Pharmacodyn. 2019 Apr;46(2):111-116. doi: 10.1007/s10928-019-09621-y. Epub 2019 Apr 19. Review.

PMID:
31004315
15.

Meta-analyses identify differentially expressed micrornas in Parkinson's disease.

Schulz J, Takousis P, Wohlers I, Itua IOG, Dobricic V, Rücker G, Binder H, Middleton L, Ioannidis JPA, Perneczky R, Bertram L, Lill CM.

Ann Neurol. 2019 Jun;85(6):835-851. doi: 10.1002/ana.25490.

PMID:
30990912
16.

Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis.

Levis B, Benedetti A, Thombs BD; DEPRESsion Screening Data (DEPRESSD) Collaboration.

BMJ. 2019 Apr 9;365:l1476. doi: 10.1136/bmj.l1476. Erratum in: BMJ. 2019 Apr 12;365:l1781.

17.

The Importance of Predefined Rules and Prespecified Statistical Analyses: Do Not Abandon Significance.

Ioannidis JPA.

JAMA. 2019 Apr 4. doi: 10.1001/jama.2019.4582. [Epub ahead of print] No abstract available.

PMID:
30946431
18.

Therapy and prevention for mental health: What if mental diseases are mostly not brain disorders?

Ioannidis JPA.

Behav Brain Sci. 2019 Jan;42:e13. doi: 10.1017/S0140525X1800105X.

PMID:
30940221
19.

How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation.

Ioannidis JPA, Kim BYS, Trounson A.

Nat Biomed Eng. 2018 Nov;2(11):797-809. doi: 10.1038/s41551-018-0314-y. Epub 2018 Nov 8.

20.

Bayes factors for superiority, non-inferiority, and equivalence designs.

van Ravenzwaaij D, Monden R, Tendeiro JN, Ioannidis JPA.

BMC Med Res Methodol. 2019 Mar 29;19(1):71. doi: 10.1186/s12874-019-0699-7.

Supplemental Content

Loading ...
Support Center